首頁 › 白血病 › 賓夕法尼亞州 › Philadelphia
Philadelphia, PA 的 白血病 臨床試驗
12 項針對 白血病 的研究正在 Philadelphia（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中觀察性研究
- Children's Hospital of Philadelphia, Philadelphia
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
招募中1/2 期
- University of Pennsylvania, Philadelphia
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
招募中1 期
- Children's Hospital of Philadelphia, Philadelphia
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- University of Pennsylvania, Philadelphia
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
招募中2 期
- Children's Hospital of Philadelphia, Philadelphia
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
招募中觀察性研究
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- Children's Hospital of Philadelphia, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中觀察性研究
- Saint Christopher's Hospital for Children, Philadelphia
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- Hospital of the University of Pennsylvania, Philadelphia
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
招募中早期第 1 期
- Children's Hospital of Philadelphia, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Philadelphia
其他城市的 白血病 試驗
- Houston, TX28 項研究
- Boston, MA25 項研究
- New York City, NY19 項研究
- Los Angeles, CA16 項研究
- Chicago, IL16 項研究
- Durham, NC13 項研究
- Columbus, OH12 項研究
- Baldwin Park, CA12 項研究
- Nashville, TN12 項研究
- Milwaukee, WI11 項研究
- Atlanta, GA11 項研究
- Seattle, WA11 項研究
Philadelphia 的其他研究
- 癌症（所有類型）59 項研究
- 乳癌56 項研究
- 非小細胞肺癌51 項研究
- 轉移性癌症46 項研究
- 大腸直腸癌44 項研究
- 卵巢癌44 項研究
- 前列腺癌44 項研究
- 肺癌36 項研究
- 急性髓系白血病34 項研究
- 心臟衰竭31 項研究
- 子宮內膜癌28 項研究
- 憂鬱症26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。